In this issue of Clinics in Laboratory Medicine, guest editors Drs. Christopher P. Holstege and Joshua D. King bring their considerable expertise to the topic of COVID-19 Molecular Testing and Clinical Correlates. Top experts in the field cover key topics such as point-of-care molecular assays for SARS-CoV-2; strategies for scaling up SARS-CoV-2 molecular testing capacity; cycle threshold values from SARS-CoV-2 PCR assays; and more.
Analytic and Clinical Performance of Major Commercial Severe Acute Respiratory Syndrome Coronavirus 2 Molecular Assays in the United States The Successes and Challenges of SARS-CoV-2 Molecular Testing in the United States An Overview of SARS-CoV-2 Molecular Diagnostics in Europe SARS-CoV-2 Molecular Diagnostics in China Rapid Antigen Assays for SARS-CoV-2: Promise and Peril Clinical Diagnostic Point-of-Care Molecular Assays for SARS-CoV-2 Cycle Threshold Values from Severe Acute Respiratory Syndrome Coronavirus-2 Reverse Transcription-Polymerase Chain Reaction Assays: Interpretation and Potential Use Cases Performance of Non-nasopharyngeal Sample Types for Molecular Detection of SARS-CoV-2 Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity Approaches to Deployment of Molecular Testing for SARS-CoV-2 in Resource-Limited Settings Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.